PRL is a mitogenic hormone that shares many characteristics with growt
h factors. The recent demonstration that rat mammary tissue expresses
PRL messenger RNA (mRNA) led us to hypothesize that PRL may act as an
autocrine/paracrine growth factor in the mammary gland and may be a de
terminant in mammary carcinogenesis. To examine this, mammary tumors w
ere induced in rats by injection of the carcinogen nitrosomethylurea (
NMU). In vitro studies used a cell line derived from NMU-induced mamma
ry tumors. Expression of PRL and PRL receptor was assessed by reverse
transcriptase-polymerase chain reaction. The NMU-induced mammary tumor
s and the cell line express mRNA for both PRL and PRL receptor (the lo
ng and short isoforms); additional hybridizing polymerase chain reacti
on products were seen in the tumors, but not in lactating mammary tiss
ue. Immunoreactive PRL was detected in the NMU-induced tumors. The eff
ect of PRL on cell proliferation was assessed by culturing NMU cells w
ith PRL antiserum. The PRL antiserum inhibited cell proliferation by u
p to 70% compared to the effect of normal rabbit serum or GH antiserum
. In summary, we showed that NMU-induced mammary tumors express mRNA f
or PRL and PRL receptor. Addition of PRL antiserum to cultured NMU cel
ls significantly inhibited their growth. We propose that PRL may be ac
ting as a local growth factor that stimulates the proliferation of mam
mary tumors.